MMI Monthly: Public Health Stories from Bench to Breakthrough

MMI Monthly: Public Health Stories from Bench to Breakthrough
Podcast Description
MMI Monthly's podcast, "Public Health Stories from Bench to Breakthrough," highlights scientific research and advances in the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health.
Podcast Insights
Content Themes
The podcast focuses on themes related to public health advancements and scientific research, with episode highlights that include discussions on the integration of philosophy in science education and the journey of COVID-19 convalescent plasma therapy from emergency use to FDA approval, emphasizing the importance of rigorous scientific inquiry and learning from historical experiences.

MMI Monthly’s podcast, “Public Health Stories from Bench to Breakthrough,” highlights scientific research and advances in the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health.
Over 90% of vector-borne diseases in the U.S. are tick-borne. Yet, prevention tools and treatments remain limited. Today, we discuss Lyme disease — what it is, why it’s hard to fight, and how researchers are tackling it at the immune level. We also offer some tips on how to protect yourself from those pesky tick bites!
With Professor Nicole Baumgarth, Director Lyme and Tickborne Diseases Research and Education Institute at the Bloomberg School of Public Health.

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.